{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:08:06Z","timestamp":1787987286060,"version":"build-2784847793"},"publisher-location":"Chichester, UK","reference-count":83,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004425.pub3","type":"reference-entry","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T13:35:23Z","timestamp":1169732123000},"source":"Crossref","is-referenced-by-count":18,"title":["Combined oral contraceptive pills for treatment of acne"],"prefix":"10.1002","author":[{"given":"Ayodele O","family":"Arowojolu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"key":"10.1002\/14651858.CD004425.pub3-BIB1|cit1","first-page":"547","article-title":"Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane","volume":"104","author":"Aydinlik","year":"1986","journal-title":"Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD004425.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/00016348609157049","article-title":"Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study","volume":"134","author":"Carlborg","year":"1986","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD004425.pub3-BIB3|cit3","first-page":"423","article-title":"Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate","volume":"41","author":"Charoenvisal","year":"1996","journal-title":"International Journal of Fertility and Menopausal Studies"},{"key":"10.1002\/14651858.CD004425.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0010-7824(94)90024-8","article-title":"The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne","volume":"50","author":"Dieben","year":"1994","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB5|cit5","first-page":"590","article-title":"The comparative efficacy and safety of Diane-35 versus Diane-50 in the treatment of moderate to severe acne and seborrhea: 12-month results","volume":"1","author":"Fugere","year":"1988","journal-title":"Recent Research on Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0010-7824(90)90106-6","article-title":"Cyproterone acetate\/ethinyl estradiol in the treatment of acne. A comparative dose-response study of the estrogen component","volume":"42","author":"Fugere","year":"1990","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/13625189809051413","article-title":"Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene","volume":"3","author":"Halbe","year":"1998","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD004425.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0010-7824(95)00037-B","article-title":"Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women","volume":"51","author":"Koetsawang","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB9|cit9","first-page":"1922","article-title":"[Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon]","volume":"72","author":"Lachnit-Fixson","year":"1977","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD004425.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 ug of ethinyl estradiol and 100 ug of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/cjwh.2001.25638","article-title":"Use of low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris","volume":"1","author":"Maloney","year":"2001","journal-title":"Clinical Journal of Women's Health"},{"key":"10.1002\/14651858.CD004425.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0010-7824(96)00005-4","article-title":"Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris","volume":"53","author":"Mango","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2230.1987.tb02499.x","article-title":"Efficacy of low-dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris","volume":"12","author":"Monk","year":"1987","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2340\/0001555564517523","article-title":"Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives","volume":"64","author":"Palatsi","year":"1984","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD004425.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2340\/0001555566225230","article-title":"Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne","volume":"66","author":"Palatsi","year":"1986","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD004425.pub3-BIB17|cit17","first-page":"286","article-title":"The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris","volume":"43","author":"Olson","year":"1998","journal-title":"International Journal of Fertility and Women's Medicine"},{"key":"10.1002\/14651858.CD004425.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1067\/mob.2003.294","article-title":"A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris","volume":"188","author":"Rosen","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 \u00b5g of ethinyl estradiol and 100 \u00b5g of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004425.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB22|cit22","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD004425.pub3-BIB23|cit23","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69 Suppl (4)","author":"Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD004425.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/ejc.6.1.46.53","article-title":"Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate","volume":"6","author":"Vartiainen","year":"2001","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD004425.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.contraception.2003.12.017","article-title":"Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 \u00b5g ethinylestradiol","volume":"69","author":"Winkler","year":"2004","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE\/CMA (Belara) and EE\/LNG (Microgynon)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB27|cit27","first-page":"384","article-title":"Effect of androgen-dominant and estrogen-dominant oral contraceptives on acne","volume":"4","author":"Barranco","year":"1974","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD004425.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF03345509","article-title":"The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne","volume":"25","author":"Carmina","year":"2002","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1002\/14651858.CD004425.pub3-BIB29|cit29","first-page":"347","article-title":"Clinical evidence of minimal androgenic activity of norgestimate","volume":"34","author":"Chapdelaine","year":"1989","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD004425.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0010-7824(01)00208-6","article-title":"Weight change and adverse event incidence with a low dose contraceptive: two randomized, placebo-controlled trials","volume":"63","author":"Coney","year":"2001","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB31|cit31","first-page":"299","article-title":"Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol","volume":"7","author":"Cremoncini","year":"1976","journal-title":"Acta Europaea Fertilitatis"},{"key":"10.1002\/14651858.CD004425.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003495-200464070-00005","article-title":"Ethinylestradiol\/ chlormadinone acetate","volume":"64","author":"Curran","year":"2004","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD004425.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/s-2007-1022354","article-title":"Ovarian suppression with Diane 35\/50","volume":"54","author":"Erdmann","year":"1994","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"10.1002\/14651858.CD004425.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00016349009021041","article-title":"Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms","volume":"69","author":"Erkkola","year":"1990","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD004425.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a uniqiue oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"Journal of Women's Health & Gender-based Medicine"},{"key":"10.1002\/14651858.CD004425.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bmj.291.6504.1231","article-title":"Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment","volume":"291","author":"Greenwood","year":"1985","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD004425.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.134.4.459","article-title":"Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial","volume":"134","author":"Gruber","year":"1998","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00024677-200605020-00005","article-title":"A comparison of the cycle control, safety, and efficacy profile of a 21-day regimen of ethinylestradiol 20\u00b5g and drospirenone 3mg with a 21-day regimen of ethinylestradiol 20\u00b5g and desogestrel 150\u00b5g","volume":"5","author":"Gruber","year":"2006","journal-title":"Treatments in Endocrinology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB39|cit39","first-page":"2180","article-title":"The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate)","volume":"26","author":"Grund","year":"1975","journal-title":"Die Medizinische Welt"},{"key":"10.1002\/14651858.CD004425.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD004425.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/13625180008500411","article-title":"Effect of a desogestrel-containing oral contraceptive on the skin","volume":"5","author":"Katz","year":"2000","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD004425.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00016347909157227","article-title":"The development and evaluation of an ovulation inhibitor (DIAne) containing an antiandrogen","volume":"88","author":"Lachnit-Fixson","year":"1979","journal-title":"Acta Obstetricia et Gynecologica Scandinavica. Supplement"},{"key":"10.1002\/14651858.CD004425.pub3-BIB43|cit43","first-page":"50","article-title":"Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive","volume":"106","author":"Mehrl","year":"1988","journal-title":"Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD004425.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2133.1986.tb04880.x","article-title":"Anti-androgen treatment in women with acne: a controlled trial","volume":"114","author":"Miller","year":"1986","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB45|cit45","first-page":"1","article-title":"Clinical studies on oral contraceptives--a randomized, doubleblind, crossover study of 4 different preparations (Anovlar(R) mite, Lyndiol(R) mite, Ovulen(R), and Volidan)","volume":"46: Suppl (8)","author":"Nilsson","year":"1967","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD004425.pub3-BIB46|cit46","first-page":"6","article-title":"Oral contraceptives and their minor side effects: comparison between three low-dose estroprogestinic associations","volume":"15","author":"Perrone","year":"1987","journal-title":"Patologia e Clinica Ostetrica e Ginecologica"},{"key":"10.1002\/14651858.CD004425.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-7824(79)90042-8","article-title":"A randomized double blind study of two oral contraceptives","volume":"20","author":"Sanhueza","year":"1979","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000292281","article-title":"An open randomized comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long-term treatment of hirsutism","volume":"41","author":"Vegetti","year":"1966","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD004425.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0010-7824(88)90083-2","article-title":"Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women","volume":"38","author":"Vermeulen","year":"1988","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effect of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0028-2243(94)90120-1","article-title":"Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel","volume":"53","author":"Volpe","year":"1994","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0010-7824(93)90076-J","article-title":"Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial","volume":"48","author":"Weber-Diehl","year":"1993","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0010-7824(96)87703-1","article-title":"The influence of Microgynon and Diane-35, two sub-fifty ovulation inhibitors, on voice function in women","volume":"52","author":"Wendler","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1440-0960.1991.tb00683.x","article-title":"An open study of Triphasil and Diane 50 in the treatment of acne","volume":"32","author":"Wishart","year":"1991","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB56|cit56","first-page":"118","article-title":"Placebo-controlled study of the acne therapeutics with the association of ethynilestradiol and cyproterone acetate","volume":"7","author":"Cardim","year":"1996","journal-title":"Rev Ginecol Obstet"},{"key":"10.1002\/14651858.CD004425.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9378(99)70362-5","article-title":"Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 \u00b5g levonorgestrel and 20 \u00b5g ethinyl estradiol (Alesse)","volume":"181 Suppl (5 Pt","author":"Archer","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB58|cit58","first-page":"133","article-title":"The interaction between acne vulgaris and the psyche","volume":"70","author":"Baldwin","year":"2002","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD004425.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0190-9622(95)90421-2","article-title":"The evaluation and management of acne: economic considerations","volume":"32 Suppl (5 Pt","author":"Bergfeld","year":"1995","journal-title":"Journal of American Academy of Dermatology."},{"key":"10.1002\/14651858.CD004425.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/120347540000400305","article-title":"Effects of benzoyl peroxide on lipogenesis in sebaceous glands using animal model","volume":"4","author":"Burkhart","year":"2000","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"key":"10.1002\/14651858.CD004425.pub3-BIB61|cit61","first-page":"103","article-title":"Effects of sex steroids on skin 5 alpha-reductase activity in vitro","volume":"78","author":"Cassidenti","year":"1991","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(99)00019-0","article-title":"Cycle control with oral contraceptives containing 20 \u00b5g ethinyl estradiol. A multicenter, randomized comparison of levonogestrel\/ethinyl estradiol (100 \u00b5g\/20 \u00b5g) and norethindrone\/ethinyl estradiol (1000 \u00b5g\/20 \u00b5g)","volume":"59","author":"DelConte","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1365-2133.2002.04946.x","article-title":"Modelling the remission of individual acne lesion in vitro","volume":"147","author":"Downie","year":"2002","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.1994.tb08519.x","article-title":"Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients","volume":"131","author":"Eady","year":"1994","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(94)90106-6","article-title":"New progestogens in oral contraception","volume":"49","author":"Fotherby","year":"1994","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB66|cit66","first-page":"577","article-title":"Prevalence of facial acne in adults","volume":"41","author":"Goulden","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB67|cit67","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] www.cochrane.dk\/cochrane\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD004425.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000057878","article-title":"Have oral contraceptives reduced the prevalence of acne? A population-based study of acne vulgaris, tobacco smoking and oral contraceptives","volume":"204","author":"Jemec","year":"2002","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD004425.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199704173361607","article-title":"Therapy for acne vulgaris","volume":"336","author":"Leyden","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004425.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004425.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004425.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)02382-5","article-title":"Oral contraceptives and fatal pulmonary embolism","volume":"355","author":"Parkin","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004425.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1468-3083.2001.00357.x","article-title":"An epidemiological study of acne in female adults: results of a survey conducted in France","volume":"15","author":"Poli","year":"2001","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09513590009167685","article-title":"Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro","volume":"14","author":"Rabe","year":"2000","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ije\/31.1.150","article-title":"Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed","volume":"31","author":"Robinson","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004425.pub3-BIB77|cit77","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004425.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004425.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/humrep\/deg090","article-title":"Differences in the use of combined contraceptives amongst women with and without acne","volume":"18","author":"Seaman","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004425.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archfami.9.2.179","article-title":"New treatments and therapeutic strategies for acne","volume":"9","author":"Thiboutot","year":"2000","journal-title":"Archives of Family Medicine"},{"key":"10.1002\/14651858.CD004425.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s007950100002","article-title":"Pathogenesis of acne","volume":"34","author":"Toyoda","year":"2001","journal-title":"Medical Electron Microscopy"},{"key":"10.1002\/14651858.CD004425.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004425.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bmj.325.7362.475","article-title":"Acne vulgaris","volume":"325","author":"Webster","year":"2002","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004425.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T13:00:10Z","timestamp":1707570010000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004425.pub3"}},"subtitle":[],"editor":[{"given":"Ayodele O","family":"Arowojolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":83,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004425.pub3","relation":{},"subject":[],"published":{"date-parts":[[2007,1,24]]}}}